POPULATION PK AND EXPOSURE-RESPONSE ANALYSES OF APREMILAST IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS

被引：0
|
作者：
Kassir, N. [1 ]
Savant, I. [2 ]
Mouksassi, M. S. [1 ]
Marier, J. F. [1 ]
Zhu, W. [2 ]
Lau, H. [2 ]
机构：
[1] Pharsight Corp, Montreal, PQ, Canada
[2] Celgene Corp, Summit, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [1] Population Pharmacokinetic and Exposure-Response Analyses of Apremilast in Subjects with Active Psoriatic Arthritis
    Liu, Yong
    Kassir, Nastya
    Mouksassi, Samer
    Zhou, Simon
    Marier, Jean-Francois
    Palmisano, Maria
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S34 - S35
  • [2] Population Pharmacokinetics and Exposure-Response Analyses for Risankizumab in Patients with Active Psoriatic Arthritis
    Thakre, Neha
    D'Cunha, Ronilda
    Goebel, Aline
    Liu, Wei
    Pang, Yinuo
    Suleiman, Ahmed A.
    RHEUMATOLOGY AND THERAPY, 2022, 9 (06) : 1587 - 1603
  • [3] Population pharmacokinetics and exposure-response modeling analyses of guselkumab in patients with psoriatic arthritis
    Chen, Yang
    Miao, Xin
    Hsu, Chyi-Hung
    Zhuang, Yanli
    Kollmeier, Alexa
    Xu, Zhenhua
    Zhou, Honghui
    Sharma, Amarnath
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (03): : 749 - 760
  • [4] POPULATION PHARMACOKINETICS OF APREMILAST (CC-10004) IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS
    Savan, I.
    Mouksassi, M. S.
    Kassir, N.
    Marier, J. F.
    Zhu, Wei
    Lau, H.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1088 - 1088
  • [5] Population Pharmacokinetics and Exposure–Response Analyses for Risankizumab in Patients with Active Psoriatic Arthritis
    Neha Thakre
    Ronilda D’Cunha
    Aline Goebel
    Wei Liu
    Yinuo Pang
    Ahmed A. Suleiman
    Rheumatology and Therapy, 2022, 9 : 1587 - 1603
  • [6] Population pharmacokinetic and exposure-response analysis of apremilast in Japanese subjects with moderate to severe psoriasis
    Okubo, Yukari
    Ohtsuki, Mamitaro
    Komine, Mayumi
    Imafuku, Shinichi
    Kassir, Nastya
    Petric, Rosemary
    Nemoto, Osamu
    JOURNAL OF DERMATOLOGY, 2021, 48 (11): : 1652 - 1664
  • [7] Population Pharmacokinetics and Exposure-Response Analyses for Abatacept in Juvenile Idiopathic Arthritis
    Li, X.
    Passarell, J. A.
    Lin, K.
    Roy, A.
    Murthy, B.
    Girgis, I. G.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S127 - S128
  • [8] Population pharmacokinetic and exposure-response analyses for efficacy and safety of risankizumab in subjects with active Crohn's disease
    Suleiman, A.
    Goebel, A.
    Bhatnagar, S.
    D'Cunha, R.
    Liu, W.
    Pang, Y.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I514 - I516
  • [9] Population pharmacokinetic and exposure-response analyses for efficacy and safety of risankizumab in subjects with active Crohn's disease
    Suleiman, A.
    Goebel, A.
    Bhatnagar, S.
    D'Cunha, R.
    Liu, W.
    Pang, Y.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I514 - I516
  • [10] Adjunctive Perampanel In Paediatric Patients With Epilepsy: Population Pharmacokinetic (PK) And Exposure-Response Analyses
    Majid, O.
    Reyderman, L.
    Ferry, J.
    Hussein, Z.
    EPILEPSIA, 2019, 60 : 107 - 108
12345